Back to Search
Start Over
European Commission approves AbbVie's Skyrizifor to treat adults with active psoriatic arthritis
- Source :
- PharmaBiz. November 18, 2021
- Publication Year :
- 2021
-
Abstract
- AbbVie announced that the European Commission (EC) has approved Skyrizi (risankizumab, 150 mg, subcutaneous injection at week 0, week 4 and every 12 weeks thereafter) alone or in combination with [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PharmaBiz
- Publication Type :
- Periodical
- Accession number :
- edsgcl.682994648